{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:34:21Z","timestamp":1792596861495,"version":"4.5.0"},"reference-count":67,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T00:00:00Z","timestamp":1732233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Alzheimer\u2019s disease (AD) is one of the most prevalent forms of dementia globally and remains an incurable condition that often leads to death. PANoptosis represents an emerging paradigm in programmed cell death, integrating three critical processes: pyroptosis, apoptosis, and necroptosis. Studies have shown that apoptosis, necroptosis, and pyroptosis play important roles in AD development. Therefore, targeting PANoptosis genes might lead to novel therapeutic targets and clinically relevant therapeutic approaches. This study aims to identify different molecular subtypes of AD and potential drugs for treating AD based on PANoptosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Differentially expressed PANoptosis genes associated with AD were identified via Gene Expression Omnibus (GEO) dataset GSE48350, GSE5281, and GSE122063. Least Absolute Shrinkage and Selection Operator (LASSO) regression was employed to construct a risk model linked to these PANoptosis genes. Consensus clustering analysis was conducted to define AD subtypes based on these genes. We further performed gene set variation analysis (GSVA), functional enrichment analysis, and immune cell infiltration analysis to investigate differences between the identified AD subtypes. Additionally, a protein-protein interaction (PPI) network was established to identify hub genes, and the DGIdb database was consulted to identify potential therapeutic compounds targeting these hub genes. Single-cell RNA sequencing analysis was utilized to assess differences in gene expression at the cellular level across subtypes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 24 differentially expressed PANoptosis genes (APANRGs) were identified in AD, leading to the classification of two distinct AD subgroups. The results indicate that these subgroups exhibit varying disease progression states, with the early subtype primarily linked to dysfunctional synaptic signaling. Furthermore, we identified hub genes from the differentially expressed genes (DEGs) between the two clusters and predicted 38 candidate drugs and compounds for early AD treatment based on these hub genes. Single-cell RNA sequencing analysis revealed that key genes associated with the early subtype are predominantly expressed in neuronal cells, while the differential genes for the metabolic subtype are primarily found in endothelial cells and astrocytes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In summary, we identified two subtypes, including the AD early synaptic abnormality subtype as well as the immune-metabolic subtype. Additionally, ten hub genes, SLC17A7, SNAP25, GAD1, SLC17A6, SLC32A1, PVALB, SYP, GRIN2A, SLC12A5, and SYN2, were identified as marker genes for the early subtype. These findings may provide valuable insights for the early diagnosis of AD and contribute to the development of innovative therapeutic strategies.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2024.1462003","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:19:27Z","timestamp":1732256367000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Identification of early Alzheimer\u2019s disease subclass and signature genes based on PANoptosis genes"],"prefix":"10.3389","volume":"15","author":[{"given":"Wenxu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningyun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingcen","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13195-015-0118-1","article-title":"Is the risk of Alzheimer\u2019s disease and dementia declining","volume":"7","author":"Langa","year":"2015","journal-title":"Alzheimer\u2019s Res Ther"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2011.09.010","article-title":"Changes in cognition","volume":"32","author":"Albert","year":"2011","journal-title":"Neurobiol Aging"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170163","article-title":"Neurofibrillary tangles of A\u03b2 x-40 in alzheimer\u2019s disease brains","volume":"58","author":"Lacosta","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/475S1a","article-title":"Alzheimer\u2019s disease","volume":"475","author":"Brody","year":"2011","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer\u2019s disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2310168","article-title":"Biomarker changes during 20 years preceding alzheimer\u2019s disease","volume":"390","author":"Jia","year":"2024","journal-title":"New Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00168-5","article-title":"Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials","volume":"21","author":"Ossenkoppele","year":"2022","journal-title":"Lancet Neurol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: The core pathogenesis and mechanism of Alzheimer\u2019s disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res Rev"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2019.00406","article-title":"ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis)","volume":"9","author":"Malireddi","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00238","article-title":"The PANoptosome: A deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"10","author":"Samir","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.789610","article-title":"PANoptosis: A new insight into oral infectious diseases","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1023\/A:1009625323388","article-title":"Apoptosis in Alzheimer\u2019s disease\u2013an update","volume":"5","author":"Shimohama","year":"2000","journal-title":"Apoptosis: An Int J Programmed Cell Death"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.872471","article-title":"Research progress of pyroptosis in alzheimer\u2019s disease","volume":"15","author":"Xue","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4438","DOI":"10.1016\/j.cell.2023.08.005","article-title":"Early Alzheimer&x2019;s disease pathology in human cortex involves transient cell states","volume":"186","author":"Gazestani","year":"2023","journal-title":"Cell"},{"key":"B17","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41467-023-36519-8","article-title":"Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice","volume":"14","author":"Park","year":"2023","journal-title":"Nat Commun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1197152","article-title":"PANoptosis-based molecular subtyping and HPAN-index predicts therapeutic response and survival in hepatocellular carcinoma","volume":"14","author":"Song","year":"2023","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41420-021-00451-x","article-title":"A novel defined pyroptosis-related gene signature for predicting the prognosis of ovarian cancer","volume":"7","author":"Ye","year":"2021","journal-title":"Cell Death Discovery"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"B21","volume-title":"R package \u201ccorrplot\u201d: visualization of a correlation matrix","author":"Wei T","year":"2017"},{"key":"B22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinf"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database hallmark gene set collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Systems"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinf (Oxford England)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat Methods"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume-title":"Genome Res","author":"Shannon","year":""},{"key":"B27","doi-asserted-by":"publisher","first-page":"e13984","DOI":"10.1371\/journal.pone.0013984","article-title":"Enrichment map: a network-based method for gene-set enrichment visualization and interpretation","volume":"5","author":"Merico","year":"2010","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.12688\/f1000research","article-title":"AutoAnnotate: A Cytoscape app for summarizing networks with semantic annotations","volume":"5","author":"Kucera","year":"2016","journal-title":"F1000Research"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"B30","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","article-title":"cytoHubba: identifying hub objects and sub-networks from complex interactome","author":"Chin","year":"2014","journal-title":"BMC Syst Biol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.2689","article-title":"DGIdb: mining the druggable genome","volume":"10","author":"Griffith","year":"2013","journal-title":"Nat Methods"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4096","article-title":"Integrating single-cell transcriptomic data across different conditions, technologies, and species","volume":"36","author":"Butler","year":"2018","journal-title":"Nat Biotechnol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1038\/s41467-023-37437-5","article-title":"Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers","volume":"14","author":"Brase","year":"2023","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac947","article-title":"CellMarker 2.0: an updated database of manually curated cell markers in human\/mouse and web tools based on scRNA-seq data","volume":"51","author":"Hu","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","article-title":"Inference and analysis of cell-cell communication using CellChat","volume":"12","author":"Jin","year":"2021","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.11.1518","article-title":"Analyses of the National Institute on Aging Late-Onset Alzheimer\u2019s Disease Family Study: implication of additional loci","volume":"65","author":"Lee","year":"2008","journal-title":"Arch Neurol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12964-024-01528-7","article-title":"Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer\u2019s disease","volume":"22","author":"Mao","year":"2024","journal-title":"Cell Communication Signaling"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101865","article-title":"The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer\u2019s disease","volume":"86","author":"Tang","year":"2023","journal-title":"Ageing Res Rev"},{"key":"B39","doi-asserted-by":"publisher","first-page":"8704","DOI":"10.3390\/ijms21228704","article-title":"Impaired expression of GABA signaling components in the alzheimer\u2019s disease middle temporal gyrus","volume":"21","author":"Govindpani","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-022-00713-x","article-title":"SNAP25 \u2014 an early biomarker in AD and CJD","volume":"18","author":"Wood","year":"2022","journal-title":"Nat Rev Neurol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"e13437","DOI":"10.1111\/acel.13437","article-title":"Knockdown of astrocytic Grin2a aggravates beta-amyloid-induced memory and cognitive deficits through regulating nerve growth factor","volume":"20","author":"Du","year":"2021","journal-title":"Aging Cell"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.neuron.2024.04.007","article-title":"MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons","volume":"112","author":"Liu","year":"2024","journal-title":"Neuron"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa147","article-title":"Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice","volume":"143","author":"Amador","year":"2020","journal-title":"Brain: J Neurol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bbr.2010.05.033","article-title":"The basal forebrain cholinergic system in aging and dementia. Rescuing cholinergic neurons from neurotoxic amyloid-\u03b242 with memantine","volume":"221","author":"Nyakas","year":"2011","journal-title":"Behav Brain Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1162846","article-title":"Development and validation of a combined hypoxia- and metabolism-related prognostic signature to predict clinical prognosis and immunotherapy responses in clear cell renal cell carcinoma","volume":"13","author":"Wu","year":"2023","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12943-018-0846-5","article-title":"Transcriptome reprogramming by cancer exosomes: identification of novel molecular targets in matrix and immune modulation","volume":"17","author":"Qadir","year":"2018","journal-title":"Mol Cancer"},{"key":"B47","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma triggers inflammatory cell death, tissue damage, and mortality in SARS-coV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1111\/imr.v321.1","article-title":"PANoptosis: Mechanisms, biology, and role in disease","volume":"321","author":"Sun","year":"2024","journal-title":"Immunol Rev"},{"key":"B49","doi-asserted-by":"publisher","first-page":"108010","DOI":"10.1016\/j.pharmthera.2021.108010","article-title":"Programming inflammatory cell death for therapy","volume":"232","author":"Christgen","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00814-y","article-title":"Molecular mechanisms of cell death in neurological diseases","volume":"28","author":"Moujalled","year":"2021","journal-title":"Cell Death Differentiation"},{"key":"B51","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1016\/j.cell.2023.05.005","article-title":"NLRP12-PANoptosome activates PANoptosis and pathology in response to heme and PAMPs","volume":"186","author":"Sundaram","year":"2023","journal-title":"Cell"},{"key":"B52","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/imr.v297.1","article-title":"The regulation of the ZBP1-NLRP3 inflammasome and its implications in pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"297","author":"Zheng","year":"2020","journal-title":"Immunol Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13287-022-02765-8","article-title":"The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer\u2019s disease: crosstalk between autophagy and apoptosis","volume":"13","author":"Qin","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nn.4608","article-title":"Necroptosis activation in Alzheimer\u2019s disease","volume":"20","author":"Caccamo","year":"2017","journal-title":"Nat Neurosci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"524","DOI":"10.3390\/biomedicines9050524","article-title":"Neuroinflammation in alzheimer\u2019s disease","volume":"9","author":"Onyango","year":"2021","journal-title":"Biomedicines"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13024-022-00522-2","article-title":"Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer\u2019s disease","volume":"17","author":"Bairamian","year":"2022","journal-title":"Mol Neurodegeneration"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019s disease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Assoc"},{"key":"B59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00401-024-02722-0","article-title":"Regulated cell death and its role in Alzheimer\u2019s disease and amyotrophic lateral sclerosis","volume":"147","author":"Thal","year":"2024","journal-title":"Acta Neuropathol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.cmet.2019.06.005","article-title":"A breakdown in metabolic reprogramming causes microglia dysfunction in alzheimer\u2019s disease","volume":"30","author":"Baik","year":"2019","journal-title":"Cell Metab"},{"key":"B61","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1186\/s12967-023-04324-y","article-title":"Identification of metabolism-related subtypes and feature genes in Alzheimer\u2019s disease","volume":"21","author":"Lian","year":"2023","journal-title":"J Trans Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00015.2020","article-title":"The complexity of Alzheimer\u2019s disease: an evolving puzzle","volume":"101","author":"Ferrari","year":"2021","journal-title":"Physiol Rev"},{"key":"B63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s13311-014-0313-y","article-title":"amp]]amp;x3b2;-amyloid peptides and amyloid plaques in alzheimer\u2019s disease","volume":"12","author":"Gouras","year":"2015","journal-title":"Neurotherapeutics"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04556-w","article-title":"Rare coding variants in ten genes confer substantial risk for schizophrenia","volume":"604","author":"Singh","year":"2022","journal-title":"Nature"},{"key":"B65","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/nrn3504","article-title":"NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease","volume":"14","author":"Paoletti","year":"2013","journal-title":"Nat Rev Neurosci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000050","article-title":"Neuropsychiatric symptoms in the prodromal stages of dementia","volume":"27","author":"Stella","year":"2014","journal-title":"Curr Opin Psychiatry"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.12.1475","article-title":"Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study","volume":"288","author":"Lyketsos","year":"2002","journal-title":"JAMA"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1462003\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T06:19:32Z","timestamp":1732256372000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2024.1462003\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,22]]},"references-count":67,"alternative-id":["10.3389\/fimmu.2024.1462003"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2024.1462003","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,22]]},"article-number":"1462003"}}